Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.23%54.03B | 8.18%213.13B | 9.85%50.39B | 7.41%197.02B | 5.31%49.45B | 8.83%57.35B | 7.70%44.35B | 7.70%45.87B | 10.36%183.42B | 10.69%46.96B |
| Cost of revenue | -4.93%3.26B | 6.85%14.82B | 21.41%3.43B | 14.80%13.87B | 10.35%3.61B | 7.75%4.25B | 21.68%3.18B | 25.66%2.83B | 20.50%12.08B | 14.19%3.28B |
| Gross profit | 8.11%50.77B | 8.28%198.31B | 9.09%46.96B | 6.89%183.15B | 4.93%45.83B | 8.91%53.1B | 6.75%41.17B | 6.70%43.04B | 9.71%171.34B | 10.44%43.68B |
| Operating expense | 8.97%33.85B | 8.52%133.55B | 14.27%31.06B | 7.09%123.06B | -1.38%31.45B | 15.97%36.33B | 9.47%28.1B | 4.43%27.18B | 7.89%114.91B | 11.23%31.89B |
| Staff costs | ---- | 12.82%23.04B | ---- | 0.66%20.42B | ---- | ---- | ---- | ---- | 5.65%20.29B | ---- |
| Selling and administrative expenses | 8.97%33.85B | 11.62%61.36B | 14.27%31.06B | 1.49%54.97B | -26.98%-36.64B | 15.97%36.33B | 9.47%28.1B | 4.43%27.18B | 8.49%54.17B | -3.38%-28.86B |
| -Selling and marketing expense | 8.97%33.85B | 10.71%13.34B | 14.27%31.06B | -2.14%12.05B | -12.52%-79.56B | 15.97%36.33B | 9.47%28.1B | 4.43%27.18B | 24.69%12.31B | -4.04%-70.71B |
| -General and administrative expense | ---- | 11.88%48.02B | ---- | 2.55%42.92B | ---- | ---- | ---- | ---- | 4.50%41.86B | ---- |
| Depreciation and amortization | ---- | 23.39%4.74B | ---- | 53.11%3.84B | ---- | ---- | ---- | ---- | 5.42%2.51B | ---- |
| -Depreciation | ---- | 28.65%4.49B | ---- | 70.29%3.49B | ---- | ---- | ---- | ---- | 3.69%2.05B | ---- |
| -Amortization | ---- | -28.69%251M | ---- | -23.48%352M | ---- | ---- | ---- | ---- | 13.86%460M | ---- |
| Other operating expenses | ---- | 1.32%44.41B | ---- | 15.49%43.83B | ---- | ---- | ---- | ---- | 8.43%37.95B | ---- |
| Operating profit | 6.44%16.92B | 7.79%64.76B | 0.21%15.9B | 6.48%60.09B | 22.00%14.39B | -3.78%16.77B | 1.33%13.07B | 10.82%15.86B | 13.63%56.43B | 8.36%11.79B |
| Net non-operating interest income (expenses) | -186.36%-63M | 16.67%-60M | -15.79%-22M | -4.35%-72M | 0.00%-17M | -5.88%-18M | 0.00%-18M | -11.76%-19M | -9.52%-69M | -6.25%-17M |
| Non-operating interest income | --0 | 1,220.00%66M | 100.00%2M | -44.44%5M | -66.67%1M | 0.00%2M | -50.00%1M | -50.00%1M | -18.18%9M | 0.00%3M |
| Non-operating interest expense | 162.50%63M | 63.64%126M | 20.00%24M | -1.28%77M | -10.00%18M | 5.26%20M | -5.00%19M | 5.26%20M | 5.41%78M | 5.26%20M |
| Net investment income | -6,050.00%-246M | -102.20%-2M | -104.00%-4M | -10.78%91M | -107.06%-6M | 89.29%-3M | 0 | 3,433.33%100M | 3,300.00%102M | 1,316.67%85M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 4.88%-39M | 92.70%-44M | 0.00%-41M | -555.43%-603M | -2,300.00%-552M | -400.00%-5M | 44.44%-5M | 30.51%-41M | -16.46%-92M | -1,050.00%-23M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -124.69%-178M | 1,425.00%53M | 836.36%721M | 8.82%-31M | 2,800.00%702M | -62.50%54M | 42.86%-4M | 119.69%77M | 75.18%-34M |
| Less:Other special charges | ---- | 126.57%178M | ---53M | -1,146.88%-670M | 416.67%31M | -2,364.52%-702M | ---- | ---- | -77.54%64M | -93.41%6M |
| Less:Write off | ---- | --0 | --0 | 63.83%-51M | --0 | --0 | 67.26%-55M | 0.00%4M | -233.02%-141M | -39.13%28M |
| Other non-operating income (expenses) | 3.23%64M | 15.05%237M | 40.91%62M | 1.98%206M | 3.13%33M | 25.00%70M | 20.41%59M | -32.31%44M | 26.25%202M | -38.46%32M |
| Income before tax | 4.34%16.64B | 7.09%64.71B | 0.03%15.95B | 6.68%60.43B | 16.75%13.81B | 0.61%17.51B | 0.36%13.16B | 11.54%15.94B | 14.92%56.64B | 9.71%11.83B |
| Income tax | 8.79%5.26B | 20.94%19.36B | 2.05%4.84B | -6.60%16.01B | -45.16%1.94B | 1.39%5.31B | -0.10%4.02B | 9.12%4.74B | 16.45%17.14B | 20.70%3.53B |
| Net income | 2.40%11.38B | 2.10%45.35B | -0.84%11.11B | 12.44%44.42B | 43.11%11.87B | 0.27%12.2B | 0.57%9.14B | 12.60%11.2B | 14.27%39.5B | 5.63%8.3B |
| Net income continuous operations | 2.40%11.38B | 2.10%45.35B | -0.83%11.11B | 12.45%44.42B | 43.13%11.87B | 0.28%12.2B | 0.56%9.14B | 12.60%11.2B | 14.27%39.5B | 5.62%8.29B |
| Noncontrolling interests | 0 | 384.62%74M | 0 | 95.83%47M | 235.00%27M | 0 | -135.62%-26M | -235.71%-19M | ||
| Net income attributable to the company | 2.40%11.38B | 2.27%45.35B | -0.85%11.11B | 12.18%44.34B | 42.80%11.87B | 0.08%12.16B | 0.03%9.11B | 12.49%11.2B | 14.59%39.53B | 6.05%8.31B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.40%11.38B | 2.27%45.35B | -0.85%11.11B | 12.18%44.34B | 42.80%11.87B | 0.08%12.16B | 0.03%9.11B | 12.49%11.2B | 14.59%39.53B | 6.05%8.31B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 2.57%12.79 | 3.04%50.9 | 0.13%12.47 | 12.42%49.4 | 43.85%13.2967 | 0.20%13.5267 | 0.00%10.1233 | 12.43%12.4533 | 14.61%43.9433 | 6.04%9.2433 |
| Diluted earnings per share | 2.57%12.79 | 3.04%50.9 | 0.13%12.47 | 12.42%49.4 | 43.89%13.2967 | 0.20%13.5267 | -0.04%10.1195 | 12.43%12.4533 | 14.62%43.9433 | 6.06%9.2411 |
| Dividend per share | 0 | 2.88%35.6667 | 0 | 60.00%34.6667 | 34.15%18.3333 | 0 | 104.17%16.3333 | 0 | 12.07%21.6667 | 13.89%13.6667 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |